BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37048633)

  • 1. Development and Validation of the Life for Low Vision Questionnaire (LIFE4LVQ) Using Rasch Analysis: A Questionnaire Evaluating Ability and Independence.
    Almpanidou S; Almaliotis D; Karamitopoulos L; Topouzis F; Konstas AG; Labiris G; Dardavesis T; Fountoulakis KN; Chatzisavvas KC; Karampatakis V
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.
    Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C
    Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catquest-9SF questionnaire: Validation in a Greek-speaking population using Rasch analysis.
    Nanos P; Kouteliari V; Panagiotopoulou EK; Papadopoulos N; Ntonti P; Labiris G
    PLoS One; 2022; 17(12):e0278683. PubMed ID: 36477289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire.
    Stelmack JA; Szlyk JP; Stelmack TR; Demers-Turco P; Williams RT; Moran D; Massof RW
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3919-28. PubMed ID: 15505037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Computer-Vision Symptom Scale (CVSS17): development and initial validation.
    González-Pérez M; Susi R; Antona B; Barrio A; González E
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4504-11. PubMed ID: 24938516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a vision and night driving questionnaire.
    Kimlin JA; Black AA; Djaja N; Wood JM
    Ophthalmic Physiol Opt; 2016 Jul; 36(4):465-76. PubMed ID: 27350185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contact Lens Impact on Quality of Life (CLIQ) Questionnaire: development and validation.
    Pesudovs K; Garamendi E; Elliott DB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2789-96. PubMed ID: 16799015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.
    Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
    Qual Life Res; 2017 Jan; 26(1):183-191. PubMed ID: 27614659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Quality of Life Impact of Refractive Correction (QIRC) Questionnaire: development and validation.
    Pesudovs K; Garamendi E; Elliott DB
    Optom Vis Sci; 2004 Oct; 81(10):769-77. PubMed ID: 15557851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Greek version of the NEI-VFQ 25.
    Labiris G; Katsanos A; Fanariotis M; Tsirouki T; Pefkianaki M; Chatzoulis D; Tsironi E
    BMC Ophthalmol; 2008 Mar; 8():4. PubMed ID: 18325083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the Patient Activation Measure a valid measure of osteoarthritis self-management attitudes and capabilities? Results of a Rasch analysis.
    Eyles JP; Ferreira M; Mills K; Lucas BR; Robbins SR; Williams M; Lee H; Appleton S; Hunter DJ
    Health Qual Life Outcomes; 2020 May; 18(1):121. PubMed ID: 32370751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability.
    Rifbjerg-Madsen S; Wæhrens EE; Danneskiold-Samsøe B; Amris K
    Health Qual Life Outcomes; 2017 May; 15(1):110. PubMed ID: 28532452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Symptom Questionnaire for Visual Dysfunctions (SQVD): A Questionnaire to Evaluate Symptoms of any Type of Visual Dysfunctions.
    Cacho-Martínez P; Cantó-Cerdán M; Lara-Lacárcel F; García-Muñoz Á
    Transl Vis Sci Technol; 2022 Feb; 11(2):7. PubMed ID: 35113128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the 21-item children's vision for living scale (CVLS) by Rasch analysis.
    Bokhary KA; Suttle C; Alotaibi AG; Stapleton F; Boon MY
    Clin Exp Optom; 2013 Nov; 96(6):566-76. PubMed ID: 23646873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rasch Analysis of the Listening Effort Questionnaire-Cochlear Implant.
    Hughes SE; Watkins A; Rapport F; Boisvert I; McMahon CM; Hutchings HA
    Ear Hear; 2021 Nov-Dec 01; 42(6):1699-1711. PubMed ID: 33950866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the functional vision questionnaire for children and young people with visual impairment: the FVQ_CYP.
    Tadić V; Cooper A; Cumberland P; Lewando-Hundt G; Rahi JS;
    Ophthalmology; 2013 Dec; 120(12):2725-2732. PubMed ID: 24120327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste.
    du Toit R; Palagyi A; Ramke J; Brian G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andhra Pradesh Eye Disease Study - Visual Function Questionnaire: further improvements in psychometric properties using Rasch analysis.
    Gothwal VK; Bagga DK
    Ophthalmic Epidemiol; 2012 Oct; 19(5):306-16. PubMed ID: 22978532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rasch Analysis of the Independent Mobility Questionnaire.
    Fenwick EK; O'Hare F; Deverell L; Ayton LN; Luu CD; McSweeney S; Bentley SA; Guymer RH; Finger RP
    Optom Vis Sci; 2016 Feb; 93(2):181-7. PubMed ID: 26657695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.